In This Article:
Press release - Regulated information
Brussels, March 13, 2025, 6:00pm CEST
In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code of Companies and Associations, Solvay SA hereby confirms that, as announced on March 6, 2025, the Company recently acquired a total of 175,300 shares of the Company on Euronext Brussels, for the purpose of meeting any delivery obligations of Solvay shares arising from grants of its 2025 long-term incentive plans.
| Date of repurchase | Number of shares | Average price paid | Max price paid | Min price paid | Total | Market |
| 07/03/2025 | 4,491 | 33.9106 | 34.74 | 32.62 | 152,292.50 | AQEU |
| 07/03/2025 | 26,132 | 33.9601 | 34.85 | 32.75 | 887,445.33 | CEUX |
| 07/03/2025 | 6,083 | 33.8991 | 34.81 | 32.64 | 206,208.23 | TQEX |
| 07/03/2025 | 48,848 | 33.9985 | 34.85 | 32.61 | 1,660,758.73 | XBRU |
| 10/03/2025 | 4,661 | 35.1788 | 35.92 | 34.15 | 163,968.39 | AQEU |
| 10/03/2025 | 32,300 | 35.2931 | 35.94 | 34.15 | 1,139,967.13 | CEUX |
| 10/03/2025 | 6,274 | 35.2099 | 35.93 | 34.16 | 220,906.91 | TQEX |
| 10/03/2025 | 46,511 | 35.1925 | 35.94 | 34.16 | 1,636,838.37 | XBRU |
As of March 10, 2025, Solvay held a total of 1,416,886 shares, spread out as follows:
-
1,220,974 Solvay shares held by Solvay SA; and
-
195,912 Solvay shares held by Solvay Stock Option Management SRL (“SSOM”), a wholly owned indirect subsidiary of Solvay SA.
Contacts
| Media relations | Investor relations |
| Peter Boelaert | Boris Cambon-Lalanne |
Safe harbor
This press release may contain forward-looking information. Forward-looking statements describe expectations, plans, strategies, goals, future events or intentions. The achievement of forward-looking statements contained in this press release is subject to risks and uncertainties relating to a number of factors, including general economic factors, interest rate and foreign currency exchange rate fluctuations, changing market conditions, product competition, the nature of product development, impact of acquisitions and divestitures, restructurings, products withdrawals, regulatory approval processes, all-in scenario of R&I projects and other unusual items. Consequently, actual results or future events may differ materially from those expressed or implied by such forward-looking statements. Should known or unknown risks or uncertainties materialize, or should our assumptions prove inaccurate, actual results could vary materially from those anticipated. The Company undertakes no obligation to publicly update or revise any forward-looking statements.